Schizophrenia, Alzheimer's disease, and anti-inflammatory agents

Schizophrenia Bulletin

Volumn 22, Issue 1, 1996, Pages 1-4

  Oken, Robert J ^a,b   McGeer, Patrick L ^c  

^a New York State Inst Basic Res D ^*  (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; DISEASE ASSOCIATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCHIZOPHRENIA;

EID: 0029881687     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.1.1     Document Type: Review

References (27)

1. Andersen, K.; Launer, L.J.; Ott, A.; Hoes, A.W.; Breteler, M.M.B.; and Hofman, A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology, 45:1441-1445, 1995.
2. Arnold, S.S.; Franz, B.R.; and Trojanowski, J.Q. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiology of Aging, 15:299-303, 1994.
3. Breitner, J.C.S.; Gau, B.A.; Welsh, K.A.; Plassman, B.L.; McDonald, W.M.; Helms, M.J.; and Anthony, J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin study. Neurology, 44:227-232, 1994.
4. Breitner, J.C.S.; Welsh, K.A.; Helms, M.J.; Gaskell, P.C.; Gau, B.A.; Roses, A.D.; Pericak-Vance, M.A.; and Saunders, A.M. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiology of Aging, 16:523-530, 1995.
5. Broe, G.A.; Henderson, A.S.; Creasey, H.; McCusker, E.; Korten, H.E.; Jorm, A.F.; Longley, W.; and Anthony, J.C. A case-control study of Alzheimer's disease in Australia. Neurology, 40:1698-1707, 1990.
6. Buhl, L., and Bojsen-Moller, M. Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Danish Medical Bulletin, 35:288-290, 1988.
7. Casanova, M.F.; Carosella, N.W.; Gold, J.M.; Kleinman, J.E.; Weinberger, D.R.; and Powers, R.E. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Research, 49:41-62, 1993.
8. Graham, D.Y.; Agrawal, N.M.; and Roth, S.H. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet, II:1277-1278, 1988.
9. Haroutunian, V.; Davidson, M.; Kanof, P.D.; Peri, D.P.; Powchik, P.; Losonczy, M.; McCrystal, J.; Purohit, D.F.; Bierer, L.M.; and Davis, K.L. Cortical cholinergic markers in schizophrenia. Schizophrenia Research, 12:137-144, 1994.
10. Haynes, R.C., Jr. Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and action of adrenocortical hormones. In: Gilman, A.G.; Rall, T.W.; Nies, A.S.; and Taylor, P., eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon Press, 1990. pp. 1431-1462.
11. Heaton, R.; Paulsen, J.S.; McAdams, L.A.; Kuck, J.; Zizook, S.; Braff, D.; Harris, J.; and Jeste, D.V. Neuropsychological deficits in schizophrenics: Relationship to age, chronicity, and dementia. Archives of General Psychiatry, 51:469-476, 1994.
12. Jenkinson, M.I.; Bliss, M.R.; Brain, A.T.; and Scott, D.L. Rheumatoid arthritis and senile dementia of the Alzheimer's type. British Journal of Rheumatology, 28:86-87, 1989.
13. Li, G.; Shen, Y.C.; Li, Y.T.; Chen, C.H.; Zhau, Y.W.; and Silverman, J.M. A case-controlled study of Alzheimer's disease in China. Neurology, 42:1481-1488, 1992.
14. Lindsay, J. (Correspondent) The Canadian study of health and aging: Risk factors for Alzheimer's disease in Canada. Neurology, 44:2073-2080, 1994.
15. Lucca, U.; Tettamanti, M.; Forloni, G.; and Spagnoli, A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biological Psychiatry, 36:854-356, 1994.
16. McGeer, P.L.; Akiyama, H.; Itagaki, S.; and McGeer, E.G. Immune system response in Alzheimer's disease. Canadian Journal of Neurological Science, 16:516-527, 1989.
17. McGeer, P.L.; Kawamata, T.; Walker, D.G.; Akiyama, H.; Tooyama, L; and McGeer, E.G. Microglia in degenerative neurological disease. Glia, 7:84-92, 1993.
18. McGeer, P.L.; McGeer, E.G.; Rogers, J.; and Sibley, J. Anti-inflammatory drugs and Alzheimer's disease. [Letter] Lancet, 335:1037, 1990.
19. McGeer, P.L., and Rogers, J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology, 42:447-449, 1992.
20. Myllykangas-Luosujarvi, R., and Isomaki, H. Alzheimer's disease and rheumatoid arthritis. British Journal of Rheumatology, 33:501-502, 1994.
21. Prohovnik, I.; Dwork, A.J.; Kaufman, M.A.; and Willson, N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophrenia Bulletin, 19(4):805-816, 1993.
22. Purohit, D.P.; Davidson, M.; Perl, D.P.; Powchik, P.; Haroutunian, V.H.; Bierer, L.M.; McCrystal, J.; Losonczy, M.; and Davis, K.L. Severe cognitive impairment in elderly schizophrenic patients: A clinicopathological study. Biological Psychiatry, 33:255-260, 1993.
23. Rich, J.B.; Rasmusson, D.X.; Folstein, M.F.; Carson, K.A.; Kawas, C.; and Brandt, J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology, 45:51-55, 1995.
24. Rogers, J.; Kirby, L.C.; Hempelman, S.R.; Berry, D.L.; McGeer, P.L.; Kaszniak, A.W.; Zalinski, J.; Cofield, M.; Mansukhani, L.; Willson, P.; and Kogan, F. Clinical trial of indomethacin Alzheimer's disease. Neurology, 43:1609-1611, 1993.
25. Sapolsky, R.M. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. Journal of Neuroscience, 5:1222-1227, 1985.
26. Soustek, Z. Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralblatt für Allgemeine Pathologie und Pathologische Anatomie, 135:25-32, 1989.
27. Wisniewski, H.M.; Constantinidis, J.; Wegiel, J.; Bobinski, M.; and Tarnawski, M. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Disease and Associated Disorders, 8:211-227, 1994.